MEDICALLY COMPLEX PREGNANCIES
Dr Shelley Wilkinson, Project Officer
Department of Obstetric Medicine,
Mater Mothers’ Hospital &
Associate Professor and Senior Principal Research Fellow,
School of Pharmacy, University of Queensland &
Director & Principal Dietician,
Lifestyle Maternity & Lifestyle Perimenopause
Brisbane, Australia
RESEARCHER PROFILE
Filmed in Brisbane, Australia | November 2025
A/Prof Shelley Wilkinson is an Advanced Accredited Practising Dietitian, Fellow of Dietitians Australia, and a leading Australian researcher in maternal health and implementation science.
She has over 30 years of experience in the field and holds a PhD in Psychology. Her passion is in health service redesign through co-creation and combining the ‘know-what’ of nutrition with the ‘know-how’ of innovative behaviour change techniques.
Currently, she is involved in the implementation and evaluation of the Obstetric Midwifery Group Practice (“OMGP”) model of care and the “4HER” post-pregnancy cardiometabolic health clinic at Mater Mothers’ Hospitals.
She is also the Director and Principal Dietitian at Lifestyle Maternity and Lifestyle PeriMenopause. Here she delivers women-focussed, evidence-based & innovative care designed to empower women with the skills and knowledge to make informed decisions for their well-being.
Assoc Prof Wilkinson has previously held prestigious fellowships, including the NHMRC TRIP fellowship and the Queensland Government-Health Research Fellowship, which focused on improving dietetic care for women with gestational diabetes and optimising service delivery for healthy gestational weight gain.
She has been recognised for her research excellence with six awards in Evidence-Based Practice and Clinical Research.
Source: Supplied
-
Therapies for chronic myeloid leukaemia
Professor Tim Hughes is an international expert in the biology and treatment of leukaemia. He led the establishment of the molecular response criteria that are used world-wide to measure response in chronic myeloid leukaemia (CML) and has led many of the key Global and National trials. His group has successfully developed predictive bioassays and molecular targets that influence the way CML patients are managed world-wide. He has published over 350 papers that have been cited over 65,000 times.
-
Cellular interactions responsible for development, maintenance, and strength of the skeleton
Professor Sims directs the Bone Cell Biology and Disease Unit at St. Vincent’s Institute of Medical Research and is a Professorial Fellow at The University of Melbourne and Australian Catholic University.
She leads a team who studies the cellular interactions responsible for development, maintenance, and strength of the skeleton. She completed her PhD at the University of Adelaide, followed by postdoctoral work at the Garvan Institute in Sydney then at Yale School of Medicine, in New Haven, Connecticut, where she studied the role of the estrogen receptor in regulating bone structure.
-
Impact of Leukaemia Foundation’s Research Funding into Blood Cancer
Bill Stavreski is the Head of Research at the Leukaemia Foundation who talks about the research impact in recent years. The Foundation itself marks its 25th anniversary in 2025, having funded a wide range of health and medical research since 2000. With a focus on basic science, health services research, treatment, and care, the organisation has invested nearly $90 million (adjusted in current dollars terms) in approximately 370 research grants over the years.
